ClinConnect ClinConnect Logo
Search / Trial NCT05619250

Supervised Center-based vs. Unsupervised Home-based Exercise Programs (PRO-Training)

Launched by UNIVERSITY OF CASTILLA-LA MANCHA · Nov 8, 2022

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Aging Exercise Physical Activity Supervised Center Based Unsupervised Home Based App Based M Health Mobile App Multicomponent Training Physical Health Mental Health Quality Of Life Physical Function Cost Effectiveness

ClinConnect Summary

This clinical trial, called PRO-Training, is looking at different types of exercise programs to see which is best for improving physical and mental health in older adults aged 60 to 75. The researchers want to find out if exercising in a supervised center is better than exercising at home on your own, and if having motivation helps people stick with their exercise routines. A total of 120 participants will be randomly assigned to one of five groups: one will not exercise at all, while the others will follow either a supervised or unsupervised exercise program, some with motivational support and some without. The exercise program will last for 24 weeks, with sessions three times a week.

To be eligible for this study, participants must be between 60 and 75 years old, able to walk independently, and able to read and speak Spanish. They should also have a smartphone and be comfortable using apps. However, those with certain medical conditions, such as severe heart issues, uncontrolled diabetes, or significant neurological diseases, will not be able to participate. Throughout the trial, participants will undergo various health assessments to measure improvements in their strength, physical fitness, mental well-being, and overall quality of life. This study aims to provide valuable insights into how different exercise approaches can benefit older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • People aged between 60 and 75 years old.
  • Being able to speak and read fluent Spanish.
  • Being able to walk independently.
  • Being physically able to participate in an exercise program.
  • Having a smartphone and being able to understand and use mobile applications autonomously.
  • Exclusion Criteria:
  • Acute or terminal illness.
  • Myocardial infarction, coronary artery bypass grafting, angioplasty, angina, or other cardiac condition in the past year.
  • Uncontrolled medical problems that the general practitioner considers would preclude patients from undertaking the exercise program (e.g., acute systemic illness such as pneumonia, acute rheumatoid arthritis, and acute or unstable heart failure).
  • Conditions requiring a specialized physical exercise program (e.g., uncontrolled epilepsy, significant neurological disease or impairment, inability to maintain an upright seated position or unable to move independently, multiple sclerosis, cancer, Parkinson's, Alzheimer's, or chronic obstructive pulmonary disease).
  • General practitioner-diagnosed hypertension that has not been controlled.
  • Type I Diabetes or uncontrolled Type II Diabetes.
  • History of major psychiatric illness including schizophrenia, generalized anxiety disorder, or depression according to the DSM-5.
  • Morbid obesity (body mass index \>39)
  • Three or more self-reported falls in the last year.
  • Not living in the community (e.g., living in nursing homes).
  • Having participated in an exercise program during the 6 months prior to the study.
  • Diagnosis of COVID-19 with hospitalization in intensive care unit.
  • Any other consideration that interferes with the study aims and could be a risk to the participant, at the discretion of the researcher and the general practitioner.

About University Of Castilla La Mancha

The University of Castilla-La Mancha is a prominent academic institution dedicated to advancing research and innovation in various fields, including health sciences. With a commitment to fostering interdisciplinary collaboration, the university engages in groundbreaking clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Its research initiatives are supported by a robust network of experts and cutting-edge facilities, positioning the university as a leading sponsor in clinical research within the region. Through its rigorous ethical standards and dedication to scientific excellence, the University of Castilla-La Mancha strives to contribute significantly to the global body of medical knowledge.

Locations

Toledo, Castilla La Mancha/Toledo, Spain

Toledo, , Spain

Patients applied

0 patients applied

Trial Officials

Asier Mañas, Ph.D.

Principal Investigator

GENUD Toledo Research Group, University of Castilla-La Mancha

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials